New Drug Shows 91% Reduction in Seizures in Children with Rare Epilepsy
A groundbreaking investigational therapy is offering new hope for children affected by Dravet syndrome, a severe and treatment-resistant form of epilepsy. The drug, known as zorevunersen, has demonstrated remarkable results in clinical trials, significantly reducing seizure frequency while also improving cognitive and behavioral outcomes.




















